Literature DB >> 25714048

Epigenetics in gastric carcinogenesis: TET genes as important players.

Laura Georgiana Necula1, Cristina Mambet, Radu Albulescu, Carmen C Diaconu.   

Abstract

Epigenetic processes including aberrant promoter methylation of tumor suppressor gene play a key role in gastric carcinogenesis. TET proteins are involved in DNA demethylation; many cancers, haematological or solid, present loss-of-function mutations and aberrant expression/regulation of TET. In gastric cancer there are few studies reporting a decreased expression of TET and associations between these proteins and signaling pathways involved in carcinogenesis. Identifying connections between aberrant expression of TET, disruption of the balance between DNA methylation and demethylation and their association with gastric carcinogenesis might be useful for the development of novel therapeutic approaches.

Entities:  

Keywords:  5hmC; TET; demethylating therapy; gastric cancer; methylation; signaling pathways

Mesh:

Substances:

Year:  2015        PMID: 25714048     DOI: 10.1080/15321819.2015.1017402

Source DB:  PubMed          Journal:  J Immunoassay Immunochem        ISSN: 1532-1819


  3 in total

1.  Immunoassay and molecular methods to investigate DNA methylation changes in peripheral blood mononuclear cells in HIV infected patients on cART.

Authors:  Adelina Rosca; Gabriela Anton; Luminita Ene; Iulia Iancu; Aura Temereanca; Cristian L Achim; Simona M Ruta
Journal:  J Immunoassay Immunochem       Date:  2016-11-17

2.  C-C motif chemokine receptors in gastric cancer.

Authors:  Hyewon Ryu; Seung Woo Baek; Ji Young Moon; In-Sook Jo; Nayoung Kim; Hyo Jin Lee
Journal:  Mol Clin Oncol       Date:  2017-10-27

3.  Induction of active demethylation and 5hmC formation by 5-azacytidine is TET2 dependent and suggests new treatment strategies against hepatocellular carcinoma.

Authors:  Bence Sipos; Andreas K Nussler; Sahar Olsadat Sajadian; Sabrina Ehnert; Haghighat Vakilian; Eirini Koutsouraki; Georg Damm; Daniel Seehofer; Wolfgang Thasler; Steven Dooley; Hossein Baharvand
Journal:  Clin Epigenetics       Date:  2015-09-11       Impact factor: 6.551

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.